Exploring starch-based excipients in pharmaceutical formulations: Versatile applications and future perspectives
- PMID: 40286879
- DOI: 10.1016/j.ejpb.2025.114727
Exploring starch-based excipients in pharmaceutical formulations: Versatile applications and future perspectives
Abstract
Starch, a naturally abundant and biocompatible polysaccharide, serves as a key excipient in pharmaceutical formulations, enhancing drug stability, efficacy, and manufacturability. This review explores the properties, modifications, and diverse applications of starch-based excipients. Native starches from corn, potato, rice, and wheat are commonly used as disintegrants, binders, and fillers. Physical (e.g., pre-gelatinization), chemical (e.g., cross-linking, acetylation), and enzymatic modifications improve their functionality, such as enhanced stability and colon-specific drug delivery. Starch excels as a binder, improving tablet cohesion and strength, and as a disintegrant, promoting rapid drug release. It also supports controlled and sustained-release systems and advanced drug delivery methods, like nanoparticles and microparticles. Compared to other natural and synthetic excipients, starch offers advantages in biodegradability, non-toxicity, and cost-effectiveness, despite challenges like stability and batch variability. Innovations such as starch nanocrystals show promise in boosting drug solubility and bioavailability. Looking ahead, starch-based excipients hold potential for sustainable pharmaceutical development, personalized medicine, and 3D printing.
Keywords: Binder; Controlled release; Disintegrant; Drug delivery; Hydrogel; Starch.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Effects of modification and incorporation techniques on disintegrant properties of wheat (Triticum aestivum) starch in metronidazole tablet formulations.Polim Med. 2014 Jul-Sep;44(3):147-55. Polim Med. 2014. PMID: 25696939
-
Advances in polysaccharide nanocrystals as pharmaceutical excipients.Carbohydr Polym. 2021 Jun 15;262:117922. doi: 10.1016/j.carbpol.2021.117922. Epub 2021 Mar 8. Carbohydr Polym. 2021. PMID: 33838801 Review.
-
Functionality of wet-granulated disintegrant in comparison to directly incorporated disintegrant in a poorly water-soluble tablet matrix.Int J Pharm. 2024 Aug 15;661:124467. doi: 10.1016/j.ijpharm.2024.124467. Epub 2024 Jul 14. Int J Pharm. 2024. PMID: 39004293
-
Simplified formulations with high drug loads for continuous twin-screw granulation.Int J Pharm. 2015 Dec 30;496(1):12-23. doi: 10.1016/j.ijpharm.2015.05.060. Epub 2015 May 27. Int J Pharm. 2015. PMID: 26024821
-
Recent advances of starch-based excipients used in extended-release tablets: a review.Drug Deliv. 2016;23(1):12-20. doi: 10.3109/10717544.2014.913324. Epub 2014 May 15. Drug Deliv. 2016. PMID: 24833274 Review.
Cited by
-
Integrated bioprocessing of cassava residues for enzymatic starch recovery, citric acid production, and effluent detoxification.Sci Rep. 2025 Jul 1;15(1):21433. doi: 10.1038/s41598-025-06841-w. Sci Rep. 2025. PMID: 40596180 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources